Halozyme Therapeutics shares owned by BI Asset Management Fondsmaeglerselskab A/S
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by BI Asset Management Fondsmaeglerselskab A/S
from 13F filings
Historical chart of BI Asset Management Fondsmaeglerselskab A/S investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by BI Asset Management Fondsmaeglerselskab A/S consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by BI Asset Management Fondsmaeglerselskab A/S
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $21M | 289k | 73.34 |
| 2025-06-30 | $23M | 445k | 52.02 |
| 2025-03-31 | $24M | 374k | 63.81 |
| 2024-12-31 | $20M | 427k | 47.81 |
| 2024-09-30 | $17M | 294k | 57.24 |
| 2024-06-30 | $1.2M | 24k | 52.34 |
| 2024-03-31 | $593k | 15k | 40.68 |
| 2023-12-31 | $4.7M | 127k | 36.96 |
| 2023-03-31 | $127k | 3.3k | 38.12 |
| 2022-12-31 | $196k | 3.4k | 56.93 |
More positions owned by BI Asset Management Fondsmaeglerselskab A/S
View all positions for BI Asset Management Fondsmaeglerselskab A/S